The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 336:988-993 April 3, 1997 Number 14
NextNext

Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions
Charles S. Rabkin, M.D., Siegfried Janz, M.D., Alex Lash, M.D., Allen E. Coleman, Elizabeth Musaba, M.D., Lance Liotta, M.D., Ph.D., Robert J. Biggar, M.D., and Zhengping Zhuang, M.D., Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Kaposi's sarcoma has features of both hyperplastic proliferation and neoplastic growth. Multiple lesions, in which spindle cells are prominent, often arise synchronously over widely dispersed areas. We tested the hypothesis that the spindle cells in these multicentric lesions originate from a single clone of precursor cells.

Methods To determine whether Kaposi's sarcoma is a monoclonal disorder, we assessed the methylation patterns of the androgen-receptor gene (HUMARA) in multiple lesions from women with the acquired immunodeficiency syndrome. In polyclonal tissues, about half the copies of each HUMARA allele are methylated, whereas in cells derived from a single clone all the copies of only one allele are methylated. To minimize contamination by normal DNA, we used microdissection to isolate areas composed primarily of spindle cells, the putative tumor cells.

Results Eight patients with a total of 32 tumors were studied. Of these tumors, 28 had highly unbalanced methylation patterns (i.e., predominant methylation of one HUMARA allele). In all the tumors that had unbalanced methylation from a given patient, the same allele predominated.

Conclusions These data indicate that Kaposi's sarcoma is a disseminated monoclonal cancer and that the changes that permit the clonal outgrowth of spindle cells occur before the disease spreads.


Source Information

From the Viral Epidemiology Branch (C.S.R., R.J.B.), the Laboratory of Genetics (S.J., A.E.C.), and the Laboratory of Pathology (A.L., L.L., Z.Z.), National Cancer Institute, Bethesda, Md.; and the University Teaching Hospital, Lusaka, Zambia (E.M.).

Address reprint requests to Dr. Rabkin at the Viral Epidemiology Branch, National Cancer Institute, EPN/434, Bethesda, MD 20892.

Full Text of this Article


Related Letters:

Clonality in Kaposi's Sarcoma
Gill P., Tsai Y., Rao A. P., Jones P., Diaz-Cano S. J., Wolfe H. J., Rabkin C. S., Janz S., Zhuang Z.
Extract | Full Text  
N Engl J Med 1997; 337:570-572, Aug 21, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.